This announcement informs that the tender offer by Wang Qingtai and Cao Xiaobing for 19,440,000 shares of Duori Pharmaceutical at a price of 32.07 CNY per share has expired on February 24, 2026. The offer represented 24.30% of the company's total share capital. Consequently, the company's stock will be suspended from trading starting February 25, 2026, until the announcement of the tender offer results.
Summary generated by AI · Always verify with source document
Securities Code: 301075
Securities Abbreviation: Duori Pharmaceutical
Announcement Number: 2026-014
Tibet Duori Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, with no false records, misleading statements, or significant omissions.
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.